Trials show that digitoxin—active ingredient in foxglove—lowered mortality & hospitalisation in patients with reduced heart-pumping function, insufficient emptying of left ventricle.
Inclisiran was developed by Novartis & launched in India in January this year under brand name Leqvio. Cardiologist vouch for benefits, say it has been a useful addition to therapies.
Report by Asia-Pacific Society of Cardiology says heart failure burden ranges from 1.3 to 6.7% in South Asian countries. Calls for ‘cancer-level’ urgency to tackle condition.
Doctors are recommending cardiac screening for competitive athletes who have recovered from Covid-19, including for those who didn't show any obvious symptoms.
Hyundai was never scared of rivals overtaking them last year. But in 2027, the mythical ‘Creta Killer’ may finally emerge. Or it could continue to remain a myth.
IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.
COMMENTS